Videos on Leukemia from our comprehensive consumer health video library. Click any title to bring up our video window. If you find that the video window does not come up, please check that your browser has JavaScript enabled and is set to allow pop-up windows.
Monitoring and Adherence in CML
Category: Leukemia
Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance.
Monitoring CML
Category: Leukemia
A wide range of laboratory tests is used to monitor a patient's response to therapy for chronic myeloid leukemia. Listen to experts explain the tests and their range of sensitivity.
Leukemia Explained
Category: Leukemia
A routine check-up may find that you have too many white blood cells, a sign of leukemia. What can be done? Learn about leukemia and how new treatments are providing hope.
Cord Blood Stem Cells
Category: Leukemia
Researchers say blood from newborns' umbilical cords may prove valuable for people requiring a bone marrow transplant after high-dose chemotherapy treatment.
Stress of Cancer
Category: Leukemia
Cancer is an upsetting experience. Worries about treatments and the future make it hard to function. Find what to do if the stress is too much to handle.
Language of CML Lab Tests
Category: Leukemia
Blood tests are routine in the treatment of chronic myeloid leukemia. Hear how one patient learned how to follow her treatment progress by studying her complicated lab tests.
CML Therapy Side Effects
Category: Leukemia
Even "targeted" therapy for chronic myeloid leukemia is not without side effects. Some, like low blood counts, are serious. Hear how one patient, along with her oncologist, Dr. Neil Shah of UCLA, managed the side effects of her CML treatment.
Gene CML
Category: Leukemia
The genetics of chronic myeloid leukemia are now well understood. Listen to researchers as they explain the path they took to their remarkable discoveries beginning over 40 years ago, in a research lab in Philadelphia.
CML after 65
Category: Leukemia
Some treatment options are not available for patients with chronic myeloid leukemia when they are over 65 years old. But most can still look forward to a range of effective medical therapies and a good quality of life. Listen to one man's success story.
CML Treatments
Category: Leukemia
Mounting evidence from clinical trials shows that patients with chronic myeloid leukemia (CML) may have long-term treatment success forgoing the only known cure for their disease. Watch and listen as CML experts explain how a promising drug now complicates the decision facing many patients-whether to seek a bone marrow transplant.
CML Facts
Category: Leukemia
In treating Chronic Myeloid Leukemia (CML), doctors admit: they don't have all the answers. So patients must learn enough about CML to help make good treatment decisions. That means understanding the natural course of the disease and how his or her own body responds to therapy. Tune in as doctors describe what CML patients need to know.
Doc/ Pat. Team
Category: Leukemia
For patients with chronic myeloid leukemia, establishing a close relationship with their doctor is very important. With new treatment options available patients and doctors need to be able to communicate freely and be aware of the latest research developments. Find out how CML patients and the doctors who treat them, can work together to treat this disease.
Targeted CLL
Category: Leukemia
Initially approved for specific types of non-Hodgkin's lymphoma, the monoclonal antibody Rituxan is now being used by to treat Chronic Lymphocytic Leukemia or CLL. At a recent medical conference, experts discussed the success of this stategy, as well as the use of other targeted therapies for CLL. Join Dr. Kanti Rai and Dr. Joseph Connors as they discuss the latest findings.
Immunotherapy
Category: Leukemia
Traditional cancer therapies like chemotherapy and radiation therapy are notorious for their severe side effects. Newer "immunotherapies," which target cancer cells and leave other cells alone, are more tolerable. But how effective are they? Tune in to learn the latest on this developing treatment strategy.
CLL Overview
Category: Leukemia
Chronic lymphocytic leukemia or CLL accounts for 25% of all leukemias in the U.S., most common in adults over 50. It affects certain white blood cells called lymphocytes with serious consequences for the body's immune system.
